Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
never received the 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in APR-2024 via intramuscular route in unknown arm). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, the patient had incomplete course of vaccination (Verbatim: never received the 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 02-OCT-2025 The reporter reported that she received the first dose of Shingrix from her local pharmacy in the last week of April 2024 (no specific date provided) and never received the second dose. The patient did not know the exact date she received the first dose of Shingrix and did not have the lot and expiry or location of administration. She have reported all that was provided about this adverse event. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination.